<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7600053</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2780</journal-id>
<journal-id journal-id-type="nlm-ta">Cancer Lett</journal-id>
<journal-id journal-id-type="iso-abbrev">Cancer Lett.</journal-id>
<journal-title-group>
<journal-title>Cancer letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">0304-3835</issn>
<issn pub-type="epub">1872-7980</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26739062</article-id>
<article-id pub-id-type="pmc">4942371</article-id>
<article-id pub-id-type="doi">10.1016/j.canlet.2015.12.028</article-id>
<article-id pub-id-type="manuscript">NIHMS760731</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Commensal bacteria modulate the tumor microenvironment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Poutahidis</surname>
<given-names>Theofilos</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Erdman</surname>
<given-names>Susan E</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">**</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139 United States</aff>
<aff id="A2"><label>2</label>Laboratory of Pathology, Faculty of Veterinary Medicine, Aristotle University of Thessaloniki, Greece 54124</aff>
<author-notes>
<corresp id="FN1">
<label>**</label>
<bold>Corresponding author:</bold>
<email>serdman@mit.edu</email>
</corresp>
<fn fn-type="conflict" id="FN3">
<p>
<bold>Disclosure of Potential Conflicts of Interest</bold>
</p>
<p>No potential conflicts of interest were disclosed.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>29</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<day>28</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>28</day>
<month>9</month>
<year>2017</year>
</pub-date>
<volume>380</volume>
<issue>1</issue>
<fpage>356</fpage>
<lpage>358</lpage>
<!--elocation-id from pubmed: 10.1016/j.canlet.2015.12.028-->
<abstract>
<p id="P1">It has been recently shown that gut microbes modulate whole host immune and hormonal factors impacting the fate of distant preneoplastic lesions toward malignancy or regression. This raises the possibility that the tumor microenvironment interacts with broader systemic microbial-immune networks. These accumulated findings suggest novel therapeutic opportunities for holobiont engineering in emerging tumor microenvironments.</p>
</abstract>
<kwd-group>
<kwd>tumor microenvironment</kwd>
<kwd>tumor macroenvironment</kwd>
<kwd>commensal microbes</kwd>
<kwd>carcinogenesis</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>